Opportunity ID: 306279

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-831
Funding Opportunity Title: The Role of Epitranscriptomics in Development and Disease (R21 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.865 — Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 14, 2018
Last Updated Date:
Original Closing Date for Applications: Jun 03, 2021
Current Closing Date for Applications: Jun 03, 2021
Archive Date: Jul 09, 2021
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
City or township governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Private institutions of higher education
County governments
State governments
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-831.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00243087 Oct 07, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259934 Oct 07, 2018 Jun 03, 2021 View

Package 1

Mandatory forms

306279 RR_SF424_2_0-2.0.pdf

306279 PHS398_CoverPageSupplement_4_0-4.0.pdf

306279 RR_OtherProjectInfo_1_4-1.4.pdf

306279 PerformanceSite_2_0-2.0.pdf

306279 RR_KeyPersonExpanded_2_0-2.0.pdf

306279 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

306279 RR_Budget_1_4-1.4.pdf

306279 RR_SubawardBudget30_1_4-1.4.pdf

306279 PHS398_ModularBudget_1_2-1.2.pdf

306279 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

306279 RR_SF424_2_0-2.0.pdf

306279 PHS398_CoverPageSupplement_5_0-5.0.pdf

306279 RR_OtherProjectInfo_1_4-1.4.pdf

306279 PerformanceSite_2_0-2.0.pdf

306279 RR_KeyPersonExpanded_2_0-2.0.pdf

306279 PHS398_ResearchPlan_4_0-4.0.pdf

306279 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

306279 RR_Budget_1_4-1.4.pdf

306279 RR_SubawardBudget30_1_4-1.4.pdf

306279 PHS398_ModularBudget_1_2-1.2.pdf

306279 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T15:42:22-05:00

Share This Post, Choose Your Platform!

About the Author: